Weight Loss Surgery Is Down 25%: Why GLP-1 Drugs Are Taking Over and What Experts Want You to Know

🦺Medically Written & ReviewedBy Dr. Ajit Jha, MBBS, MD Medicine — Lifetime Member, Indian Medical Association. About the Author  |  Editorial Policy Weight loss surgery dominated obesity treatment for over two decades. Surgeons could not keep up with demand. Hospital waiting lists stretched months long. Then, almost overnight, the operating rooms started getting quieter. The […]

Hantavirus Cruise Ship Outbreak 2026: 8 Cases, 3 Deaths – Symptoms and What You Must Know

🦺Medically Written & ReviewedBy Dr. Ajit Jha, MBBS, MD Medicine — Lifetime Member, Indian Medical Association. About the Author  |  Editorial Policy A luxury cruise ship has become the center of a global health alert. On May 2, 2026, the World Health Organization issued an emergency disease outbreak notice after a cluster of hantavirus infections […]

Why Most Indians Are Severely Omega-3 Deficient – And What It Is Doing to Your Heart, Brain, and Joints

🦺Medically Written & ReviewedBy Dr. Ajit Jha, MBBS, MD Medicine — Lifetime Member, Indian Medical Association. About the Author  |  Editorial Policy Most people have heard that omega-3 fatty acids are good for you. Far fewer realise just how profoundly their absence damages the brain and heart — or how widespread deficiency has become, particularly […]

Can Exercise Replace Ozempic? What the Science Actually Says

⚕️ Medically Reviewed This article has been reviewed by Dr. Ajit Jha, MBBS, MD Medicine, IMA Lifetime Member. Content is for informational purposes only and does not constitute medical advice. Always consult your doctor before making health decisions. As GLP-1 drugs have dominated health headlines, a provocative question has emerged: if a weekly injection can […]

What Is GIP and Why Does Mounjaro Target It Too? The Science Behind Tirzepatide’s Extra Power

⚕️ Medically Reviewed This article has been reviewed by Dr. Ajit Jha, MBBS, MD Medicine, IMA Lifetime Member. Content is for informational purposes only and does not constitute medical advice. Always consult your doctor before making health decisions. When tirzepatide (Mounjaro/Zepbound) was approved, it was described as a dual GLP-1/GIP receptor agonist. Most of the […]

Survodutide: The New Weight Loss Drug That Could Beat Ozempic and Zepbound

🦺Medically Written & ReviewedBy Dr. Ajit Jha, MBBS, MD Medicine — Lifetime Member, Indian Medical Association. About the Author  |  Editorial Policy A new weight loss drug is generating some of the most striking clinical trial results ever seen in the field of obesity medicine. Survodutide — developed by Boehringer Ingelheim and Zealand Pharma — […]